Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
LAML | rs60613582 | chr19:16245870 | GGAGTTCA/G | 7.61E-5 | 110 | 16.23 | 8.13 | 0 | KM Plot |
LAML | rs60689962 | chr2:1053513 | T/TG | 2.41E-8 | 105 | 15.17 | 16.27 | 0 | KM Plot |
LAML | rs60941325 | chr2:1882887 | C/T | 0.000134 | 110 | 13.15 | 16.23 | 0 | KM Plot |
LAML | rs609740 | chr13:71341673 | A/G | 1.71E-5 | 111 | 0 | 5 | 16.23 | KM Plot |
LAML | rs60987980 | chr2:1052002 | C/T | 1.55E-8 | 105 | 14.13 | 16.3 | 0 | KM Plot |
LAML | rs61300993 | chr2:3218725 | C/CCT | 5.94E-5 | 111 | 0 | 14.7 | 15.2 | KM Plot |
LAML | rs61627965 | chr19:33910831 | C/T | 3.24E-5 | 110 | 16.17 | 12.17 | 3 | KM Plot |
LAML | rs61733126 | chr16:71712786 | A/G | 0.000186 | 108 | 15.2 | 13.1 | 0 | KM Plot |
LAML | rs61833260 | chr10:975148 | T/G | 6.36E-5 | 111 | 15.23 | 16.17 | 5.1 | KM Plot |
LAML | rs61862752 | chr10:134970009 | T/C | 1.27E-5 | 111 | 16.3 | 17.82 | 4.05 | KM Plot |
LAML | rs61862757 | chr10:134974556 | G/C | 4.34E-5 | 111 | 16.3 | 19.33 | 3 | KM Plot |
LAML | rs61867042 | chr10:78936202 | C/T | 0.000132 | 110 | 15.23 | 15.73 | 0 | KM Plot |
LAML | rs61867043 | chr10:78945499 | T/C | 0.000118 | 111 | 14.22 | 15.73 | 0 | KM Plot |
LAML | rs61867046 | chr10:78962341 | T/C | 0.000118 | 111 | 14.22 | 15.73 | 0 | KM Plot |
LAML | rs61867048 | chr10:78972964 | C/T | 0.000118 | 111 | 14.22 | 15.73 | 0 | KM Plot |